Interní Med. 2006; 8(6): 274-279

Chronic obstructive lung disease-the importance of early diagnosis and treatment

MUDr. Vladimír Zindr
Ordinace pneumologie a diagnostiky plicních funkcí, Karlovy Vary

Chronic obstructive lung disease is a serious problem because of its prevalence, mortality and economical burden of the society. The most effective intervention is limitation of risk factor exposure. An early diagnosis is essential followed by smoking cessation. Bronchodilatation therapy brings a long-term relieve of symptoms, improved quality of life and reduction in number of exacerbations. Pulmonary rehabilitation improves the degree of dyspnoea, exercise tolerance, general health state and decreases the need of health care. An early diagnosis is a basis for optimal treatment results.

Keywords: Key words: chronic obstructive lung disease, diagnosis, forced vital capacity, cigarette smoke, smoking cessation, rehabilitation.

Published: June 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zindr V. Chronic obstructive lung disease-the importance of early diagnosis and treatment. Interní Med. 2006;8(6):274-279.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Thoracic Society. Chronic bronchitis, asthma and pulmonary emphysema: a statement by the Committee on Diagnostic Standarts for Nontuberculous Respiratory Diseases. Am Rev Respir Dis. 1962; 85: 762-768.
    2. Baarends EM, Schols AM, Mistery R, Wouters EF. Peak exercise response in relation to tissue depletion in patiens with chronic obstructive pulmonary disease. Eur Respir J. 1997; 10: 2807-2813. Go to original source... Go to PubMed...
    3. Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment od chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003; 361: 449-456. Go to original source... Go to PubMed...
    4. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002; 19: 209-216. Go to original source... Go to PubMed...
    5. Celli BR, Machre W. Standarts for the diagnosis and treatment of patiens with COPD: a summary of the ATS/ERS position paper. Eur Resp J. 2004; 23: 932-946. Go to original source... Go to PubMed...
    6. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest. 2000; 117: 1146-1161. Go to PubMed...
    7. Fletcher C, Peto R, Tanker C, Spizer FE. The natural history of chronic bronchitis: An eight year follow up study of working men in London. Oxford: Oxford University Press. 1976.
    8. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977; 1: 1645-1648. Go to original source... Go to PubMed...
    9. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000; 355: 362-368. Go to original source... Go to PubMed...
    10. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med. 1995; 333: 1196-1203. Go to original source... Go to PubMed...
    11. Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol. 1992; 11: 311-334. Go to original source...
    12. Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 1999; 5: 93-99. Go to original source... Go to PubMed...
    13. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999; 340: 685-691. Go to original source... Go to PubMed...
    14. Mallin R. Smoking cessation: intergration of behavioral and drug therapies. Am Fam Physician. 2002; 65: 1107-1114. Go to PubMed...
    15. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160: 1683-1689. Go to original source... Go to PubMed...
    16. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patiens with chronic obstructive pulmonary disease. Respir Med. 2000; 94: 859-867. Go to original source... Go to PubMed...
    17. Murray CJ, Polez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504. Go to original source... Go to PubMed...
    18. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guidelines on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004; 59 (suppl 1): 1-232.
    19. O´Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance dutiny exercise in chronic obstructive pulmonary disease. Am J. Respir Crit Care Med. 1988; 158: 1557-1565. Go to original source... Go to PubMed...
    20. O´Donnell DE, McGuire M, Samis L, Webb KA. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med. 1995; 152: 2005-2013. Go to original source... Go to PubMed...
    21. Peto R, Polez AD, Borcham J, et al. Mortality from Smoking in Developed Countries 1950-2000: Indirect Etimates from National Vital Statistics. Oxford University Press. 1994.
    22. Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med. 1999; 159: 1666-1682. Go to original source...
    23. Rennard SI, Anderson W, ZuWallack R, et al. Use of long-acting inhaled beta-2-adrenergic agonist, salmeterol xinafoate, in patiens with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163: 1087-1092. Go to original source... Go to PubMed...
    24. Scanlon PD, Connett JE, Walter LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000; 161: 381-390. Go to original source... Go to PubMed...
    25. Shoup R, Dalsky G, Warner S, et al. Body composition and health-related quality of life in patiens with obstructive airway disease. Eur Respir J. 1997; 10: 1576-1580. Go to original source... Go to PubMed...
    26. Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program. Chest. 1998; 113 (suppl 2): 123S-163S.
    27. World Health Organisation. WHO Strategy for Prevention and Control of Chronic Respiratory Diseases. 2002, WHO/MNC/CRA/ 02.1.
    28. Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax. 2002; 57: 1067-1070. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.